BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25069478)

  • 1. miR‑210 regulates esophageal cancer cell proliferation by inducing G2/M phase cell cycle arrest through targeting PLK1.
    Li C; Zhou X; Wang Y; Jing S; Yang C; Sun G; Liu Q; Cheng Y; Wang L
    Mol Med Rep; 2014 Oct; 10(4):2099-104. PubMed ID: 25069478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plumbagin inhibits the proliferation and survival of esophageal cancer cells by blocking STAT3-PLK1-AKT signaling.
    Cao YY; Yu J; Liu TT; Yang KX; Yang LY; Chen Q; Shi F; Hao JJ; Cai Y; Wang MR; Lu WH; Zhang Y
    Cell Death Dis; 2018 Jan; 9(2):17. PubMed ID: 29339720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
    Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
    Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-483-3p plays an oncogenic role in esophageal squamous cell carcinoma by targeting tumor suppressor EI24.
    Ma J; Hong L; Xu G; Hao J; Wang R; Guo H; Liu J; Zhang Y; Nie Y; Fan D
    Cell Biol Int; 2016 Apr; 40(4):448-55. PubMed ID: 26801660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma.
    Zhao C; Gong L; Li W; Chen L
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):9-16. PubMed ID: 19572149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
    Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
    Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mir-192 suppresses apoptosis and promotes proliferation in esophageal aquamous cell caicinoma by targeting Bim.
    Li S; Li F; Niu R; Zhang H; Cui A; An W; Wang X
    Int J Clin Exp Pathol; 2015; 8(7):8048-56. PubMed ID: 26339371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
    Gu MM; Li M; Gao D; Liu LH; Lang Y; Yang SM; Ou H; Huang B; Zhou PK; Shang ZF
    Toxicol Appl Pharmacol; 2018 Jun; 348():76-84. PubMed ID: 29679654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiosensitization in esophageal squamous cell carcinoma: Effect of polo-like kinase 1 inhibition.
    Chen JL; Chen JP; Huang YS; Tsai YC; Tsai MH; Jaw FS; Cheng JC; Kuo SH; Shieh MJ
    Strahlenther Onkol; 2016 Apr; 192(4):260-8. PubMed ID: 26952039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-509-3-5p causes aberrant mitosis and anti-proliferative effect by suppression of PLK1 in human lung cancer A549 cells.
    Wang XH; Lu Y; Liang JJ; Cao JX; Jin YQ; An GS; Ni JH; Jia HT; Li SY
    Biochem Biophys Res Commun; 2016 Sep; 478(2):676-82. PubMed ID: 27498003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of miR-503 Promotes ESCC Cell Proliferation, Migration, and Invasion by Targeting Cyclin D1.
    Jiang L; Zhao Z; Zheng L; Xue L; Zhan Q; Song Y
    Genomics Proteomics Bioinformatics; 2017 Jun; 15(3):208-217. PubMed ID: 28602785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-130b plays an oncogenic role by repressing PTEN expression in esophageal squamous cell carcinoma cells.
    Yu T; Cao R; Li S; Fu M; Ren L; Chen W; Zhu H; Zhan Q; Shi R
    BMC Cancer; 2015 Jan; 15():29. PubMed ID: 25637514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.
    Zhang M; Singh R; Peng S; Mazumdar T; Sambandam V; Shen L; Tong P; Li L; Kalu NN; Pickering CR; Frederick M; Myers JN; Wang J; Johnson FM
    Cancer Lett; 2017 Apr; 392():71-82. PubMed ID: 28126323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CADM2/Akt pathway is involved in the inhibitory effect of miR-21-5p downregulation on proliferation and apoptosis in esophageal squamous cell carcinoma cells.
    Li X; Chen D; Li M; Gao X; Shi G; Zhao H
    Chem Biol Interact; 2018 May; 288():76-82. PubMed ID: 29680210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-99a suppresses proliferation, migration and invasion of esophageal squamous cell carcinoma cells through inhibiting the IGF1R signaling pathway.
    Mei LL; Qiu YT; Huang MB; Wang WJ; Bai J; Shi ZZ
    Cancer Biomark; 2017 Dec; 20(4):527-537. PubMed ID: 28800315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
    Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
    J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-455-3p acts as a prognostic marker and inhibits the proliferation and invasion of esophageal squamous cell carcinoma by targeting FAM83F.
    Yang H; Wei YN; Zhou J; Hao TT; Liu XL
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3200-3206. PubMed ID: 28770965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the Na ⁺/K ⁺/2Cl⁻ cotransporter NKCC1 in cell cycle progression in human esophageal squamous cell carcinoma.
    Shiozaki A; Nako Y; Ichikawa D; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Marunaka Y; Otsuji E
    World J Gastroenterol; 2014 Jun; 20(22):6844-59. PubMed ID: 24944475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of miR-150 on Gli1 gene to inhibit proliferation and cell cycle of esophageal carcinoma EC9706.
    Sun J; Wang D; Li X; Yan J; Yuan X; Wang W
    Cancer Biomark; 2017 Dec; 21(1):203-210. PubMed ID: 29081413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.